Dartmouth Engineering Welcomes Three New Board Members

Keith Dunleavy, MD '91 P'22 P'24 P'25

Dr. Dunleavy has served as CEO of Inovalon, Inc. since his organization of the company's predecessor companies in 1998, as Chairman of the Board from 2006 to 2021, and as President from its foundation until 2014. He has worked with a wide array of healthcare organizations, regulatory and oversight bodies, and technology companies examining the growing role of data within healthcare, and its ability to drive meaningful insight and improvement for its constituents. 

Driven by his desire for a data-driven transformation of healthcare, Dunleavy has led Inovalon to its current position of leveraging advanced, cloud-based platforms informed by data pertaining to more than one million physicians, 594,000 clinical facilities, 348 million unique patients, and 68 billion medical events empowering meaningful improvements in clinical outcomes and economics across the entire healthcare ecosystem.

Dunleavy received a Dartmouth AB in biology modified with engineering sciences with an honors thesis focused on the computer simulation of artificial human cerebellar functional units. He earned his MD from Harvard, completed his medical residency at Johns Hopkins, and was board certified in internal medicine. He has authored papers, presented on, and been awarded multiple US patents pertaining to the real-time aggregation, analysis, and application of healthcare data.

Monica Martin de Bustamante '08 Th'09

Ms. Martin de Bustamante is Senior Partner for Evidence, Value, Access and Pricing at Trinity Life Sciences, providing advisory services to life sciences companies.

Martin de Bustamante's career has focused on global pricing and market access issues for biopharmaceutical and pharmaceutical products. She has worked across major therapeutic areas (oncology, cardiovascular, neurology, metabolic, autoimmune, gastrointestinal, respiratory, etc.) to collaborate on products from early development, to launch, and through their lifecycle. She has extensive global experience in early and late-stage pricing, market access strategies, value proposition development, lifecycle management, generic or biosimilar erosion counterstrategies, and patient support programs. Much of her work to date has centered around understanding the barriers to access and reimbursement challenges posed by evolving healthcare systems and evidence requirements.

Prior to Trinity, she was CEO and managing director of CBPartners, a boutique consulting company she co-founded in 2012 and sold to Trinity in October of 2021.

Martin de Bustamante also serves on the board of Angeli Parvi, a non-profit focused on providing early-stage seed investments and mentorship to Dartmouth entrepreneurs with the goal of giving back to the Dartmouth community and growing its entrepreneurial footprint.

James "Jim" TenBroek '83

TenBroek has been a private equity investor for over 25 years and has led the investment of over $1B of equity capital in over 30 companies. Currently, he is a managing partner at Growth Catalyst Partners, LLC, the private equity investment firm he co-founded in 2016, building businesses in the data, information and marketing services sectors. 

Prior to his investing career, TenBroek was an electrical engineer at Hewlett Packard's Medical Products group developing cardiac ultrasound systems, before moving into management. He is the former chairman and current executive committee member of the Illinois Venture Capital Association (IVCA), which includes over 80 of Illinois' largest private equity and venture capital investment firms.

TenBroek received an AB in engineering sciences — and the Colligan Prize for materials science — from Dartmouth, a Master of Engineering Electrical Engineering from Cornell, and an MBA from Harvard.

He lives in Illinois with his wife Sara (whom he met at Dartmouth) and their two children.

In addition, Chris McConnell '75 P'09 P'11 ThP'12 ThP'13 P'14 and Mike Ross '71 P'08 — after 12 and 30 years, respectively, of devoted service to Thayer — have completed their board terms. Both have been named emeriti members, and Thayer is deeply grateful to both McConnell and Ross for their outstanding service.